Study Title

EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)

Purpose

Determine if a strategy of monitoring for rejection that introduces AlloSure® into clinical practice does not lead to inferior renal allograft outcomes when compared to a strategy of monitoring for rejection that does not include AlloSure.

Eligibility

Medicare Part B covered renal transplant recipients selected by their providers to receive AlloSure testing as part of their practical care beginning by 2 months post-transplantation.

You Cannot:

Renal transplant recipients without Medicare Part B coverage.

Study Process

Eligible patients will receive AlloSure testing for surveillance. The recommended study visit schedule will be as follows: 1, 2, 3, 4, 6, 9, and 12 months post- transplant and then quarterly.  All samples will be collected during standard of care visits. 



Interested in more information on clinical research? Contact WK Physician Network Clinical Research at 318-212-8613

Trial Details

Investigator:

Neeraj Singh, M.D.

IRB:

Western

IRB Number:

Trial Type:

NA

Sponsor:

Care-Dx

Contact Information: